Analysis finds Tecovirimat is safe but did not improve clade I mpox resolution in Democratic Republic of the Congo
The antiviral drug tecovirimat did not reduce the duration of mpox lesions among children and adults with clade I mpox in the Democratic Republic of the Congo (DRC), based on an initial analysis of data from a randomized, ...
Aug 15, 2024
0
0